Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Liver Diseases

  Free Subscription


Articles published in AJR Am J Roentgenol

Retrieve available abstracts of 85 articles:
HTML format



Single Articles


    October 2022
  1. FETZER DT
    Reply to "Underdiagnosis of High-Risk Liver Diseases Leads to Inadequate Ultrasound Screening for Hepatocellular Carcinoma".
    AJR Am J Roentgenol. 2022 Oct 12:2. doi: 10.2214/AJR.22.28134.
    PubMed    


  2. KUO SE, Lin YJ, Wang JD
    Underdiagnosis of High-Risk Liver Diseases Leads to Inadequate Ultrasound Screening for Hepatocellular Carcinoma.
    AJR Am J Roentgenol. 2022 Oct 12:1-2. doi: 10.2214/AJR.22.28079.
    PubMed    


  3. GIAN RK
    Editorial Comment: An Algorithm to Distinguish Between Hepatocellular Adenoma Subtypes on Gadoxetate Disodium-Enhanced MRI.
    AJR Am J Roentgenol. 2022 Oct 12. doi: 10.2214/AJR.22.28613.
    PubMed    


  4. SRINIVASAN A
    Editorial Comment: Intravascular Ultrasound Facilitates TIPS Creation.
    AJR Am J Roentgenol. 2022;219:646.
    PubMed    


  5. RONOT M
    Editorial Comment: The Influence of Steatosis on Liver Stiffness Measurement-A Call for Caution, but Limited Clinical Consequences.
    AJR Am J Roentgenol. 2022;219:613.
    PubMed    


  6. KUMADA T, Toyoda H, Yasuda S, Ogawa S, et al
    Liver Stiffness Measurements by 2D Shear-Wave Elastography: Effect of Steatosis on Fibrosis Evaluation.
    AJR Am J Roentgenol. 2022;219:604-612.
    PubMed     Abstract available


    September 2022
  7. TSE JR, Felker ER, Cao JJ, Naini BV, et al
    Hepatocellular Adenoma Subtypes Based on 2017 Classification System: Exploratory Study of Gadoxetate Disodium-Enhanced MRI Features With Proposal of a Diagnostic Algorithm.
    AJR Am J Roentgenol. 2022 Sep 28. doi: 10.2214/AJR.22.28233.
    PubMed     Abstract available


  8. MAGNETTA MJ
    Editorial Comment: Is It Time to Focus on LR-M?
    AJR Am J Roentgenol. 2022;219:433.
    PubMed    


    August 2022
  9. BORHANI AA
    Editorial Comment: MRI-Based Machine-Learning Model for Prediction of Recurrence in Early Stage Hepatocellular Carcinoma.
    AJR Am J Roentgenol. 2022 Aug 31. doi: 10.2214/AJR.22.28432.
    PubMed    


  10. KIM TK
    Editorial Comment: Differentiating Hepatic Adenomas From Focal Nodular Hyperplasias With Gadoxetic Acid-Enhanced MRI-More Complicated Than Thought.
    AJR Am J Roentgenol. 2022 Aug 17. doi: 10.2214/AJR.22.28384.
    PubMed    


  11. ISEKE S, Zeevi T, Kucukkaya AS, Raju R, et al
    Machine-Learning Models for Prediction of Posttreatment Recurrence in Early-Stage Hepatocellular Carcinoma Using Pretreatment Clinical and MRI Features: A Proof-of-Concept Study.
    AJR Am J Roentgenol. 2022 Aug 17. doi: 10.2214/AJR.22.28077.
    PubMed     Abstract available


  12. KIM TH, Woo S, Ebrahimzadeh S, Mclnnes MDF, et al
    Hepatic Adenoma Subtypes on Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI: Systematic Review and Meta-Analysis.
    AJR Am J Roentgenol. 2022 Aug 3. doi: 10.2214/AJR.22.27989.
    PubMed     Abstract available


  13. TAVRI S
    Editorial Comment: FIPS Score-A New Tool With Improved Potential to Predict Post-TIPS Outcomes.
    AJR Am J Roentgenol. 2022;219:268.
    PubMed    


  14. CUNHA GM, Delgado TI, Middleton MS, Liew S, et al
    Automated CNN-Based Analysis Versus Manual Analysis for MR Elastography in Nonalcoholic Fatty Liver Disease: Intermethod Agreement and Fibrosis Stage Discriminative Performance.
    AJR Am J Roentgenol. 2022;219:224-232.
    PubMed     Abstract available


    July 2022
  15. CANNELLA R
    Editorial Comment: LI-RADS Provides High Accuracy for Liver Transplant Eligibility in High-Risk Patients.
    AJR Am J Roentgenol. 2022;219:96.
    PubMed    


  16. HUBER AT, Obmann V
    Beyond the AJR: Prognostic Value of a Single Baseline Liver Stiffness Measurement by MR Elastography in Patients With Chronic Liver Disease.
    AJR Am J Roentgenol. 2022;219:169.
    PubMed    


    June 2022
  17. BARR RG
    Editorial Comment: How Imaging Can Manage the Fatty Liver Epidemic.
    AJR Am J Roentgenol. 2022 Jun 22. doi: 10.2214/AJR.22.28113.
    PubMed    


  18. TSE JR, Shen L, Bird KN, Yoon L, et al
    Outcomes of LI-RADS US-2 Subthreshold Observations Detected on Surveillance Ultrasound.
    AJR Am J Roentgenol. 2022 Jun 15. doi: 10.2214/AJR.22.27812.
    PubMed     Abstract available


  19. DILLMAN JR, Thapaliya S, Tkach JA, Trout AT, et al
    Quantification of Hepatic Steatosis by Ultrasound: Prospective Comparison to MRI Proton-Density Fat Fraction as Reference Standard.
    AJR Am J Roentgenol. 2022 Jun 8. doi: 10.2214/AJR.22.27878.
    PubMed     Abstract available


  20. BASTAWROUS S
    Editorial Comment: Factors Impacting Ultrasound LI-RADS Visualization Scores-Optimizing Future Quality Assurance and Standards.
    AJR Am J Roentgenol. 2022;218:1020.
    PubMed    


    May 2022
  21. HULL NC
    Editorial Comment: Hepatocellular Carcinoma Screening Guidelines Are Needed in Children With Predisposing Conditions.
    AJR Am J Roentgenol. 2022 May 18. doi: 10.2214/AJR.22.27975.
    PubMed    


  22. DASTMALCHIAN S, Aryafar H, Tavri S
    Intravascular Ultrasound Guidance for Transjugular Intrahepatic Portosystemic Shunt Procedures: A Review.
    AJR Am J Roentgenol. 2022 May 18. doi: 10.2214/AJR.22.27626.
    PubMed     Abstract available


  23. KIM SH, Navot B, Guniganti P, Gavlin A, et al
    Liver Transplant for Non-Hepatocellular Malignancies: A Review for Radiologists.
    AJR Am J Roentgenol. 2022 May 11. doi: 10.2214/AJR.22.27783.
    PubMed     Abstract available


  24. REES MA, Schooler GR, Chavhan GB, Towbin AJ, et al
    Imaging Features of Hepatocellular Carcinoma in Children With and Without Underlying Risk Factors.
    AJR Am J Roentgenol. 2022 May 11. doi: 10.2214/AJR.22.27600.
    PubMed     Abstract available


  25. LUNA A
    Editorial Comment: Integrated Diagnosis of Hepatocellular Carcinoma-An Opportunity for Abdominal Radiologists.
    AJR Am J Roentgenol. 2022 May 4:12. doi: 10.2214/AJR.22.27611.
    PubMed    


  26. CANNELLA R, Lewis S, da Fonseca L, Ronot M, et al
    Immunotherapy-Based Treatments of Hepatocellular Carcinoma: AJR Expert Panel Narrative Review.
    AJR Am J Roentgenol. 2022 May 4. doi: 10.2214/AJR.22.27633.
    PubMed     Abstract available


    April 2022
  27. KING KG
    Editorial Comment: Future Incorporation of Kupffer-Cell Agents Into Contrast-Enhanced Ultrasound LI-RADS May Increase Sensitivity for HCC Without Compromising Specificity.
    AJR Am J Roentgenol. 2022 Apr 27. doi: 10.2214/AJR.22.27857.
    PubMed    


  28. LI L, Zheng W, Wang J, Han J, et al
    Contrast-Enhanced Ultrasound Using Perfluorobutane: Impact of Proposed Modified LI-RADS Criteria on Hepatocellular Carcinoma Detection.
    AJR Am J Roentgenol. 2022 Apr 20. doi: 10.2214/AJR.22.27521.
    PubMed     Abstract available


  29. WANG X, Guo Y, Yang L, Luo X, et al
    Use of an Intrahepatic Arterial Targeting Wire for Guiding Portal Vein Puncture During TIPS Creation in Patients With Obliterative Portal Vein Thrombosis.
    AJR Am J Roentgenol. 2022 Apr 13. doi: 10.2214/AJR.22.27675.
    PubMed     Abstract available


  30. KURTZ D, Wachsberg RH
    Factitious Nodularity of the Anterior Liver Surface on Prone Abdominal CT: A Potential Mimic of Cirrhosis.
    AJR Am J Roentgenol. 2022 Apr 13. doi: 10.2214/AJR.22.27669.
    PubMed    


  31. TIYARATTANACHAI T, Fetzer DT, Kamaya A
    Multicenter Study of ACR Ultrasound LI-RADS Visualization Scores on Serial Examinations: Implications for Changes in Surveillance Strategies.
    AJR Am J Roentgenol. 2022 Apr 6. doi: 10.2214/AJR.22.27405.
    PubMed     Abstract available


  32. FETZER DT
    Beyond the AJR: Shorter Ultrasound Screening Intervals for Hepatocellular Carcinoma Improve Patient Outcomes.
    AJR Am J Roentgenol. 2022;218:761.
    PubMed    


    March 2022
  33. LI J, Yin M
    Liver Fibrosis: Counterpoint-MR Elastography Is the Noninvasive Imaging Modality of Choice for Detecting and Staging Liver Fibrosis.
    AJR Am J Roentgenol. 2022 Mar 23. doi: 10.2214/AJR.22.27676.
    PubMed    


  34. PIERCE TT, Samir AE
    Liver Fibrosis: Point-Ultrasound Elastography Is a Safe, Widely Available, Low-Cost, Noninvasive Biomarker of Liver Fibrosis That Is Suitable for Broad Community Use.
    AJR Am J Roentgenol. 2022 Mar 23. doi: 10.2214/AJR.22.27639.
    PubMed    


  35. MIN JH, Lee MW, Park HS, Lee DH, et al
    LI-RADS Version 2018 Targetoid Appearances on Gadoxetic Acid-Enhanced MRI: Interobserver Agreement and Diagnostic Performance for the Differentiation of HCC and Non-HCC Malignancy.
    AJR Am J Roentgenol. 2022 Mar 23. doi: 10.2214/AJR.22.27380.
    PubMed     Abstract available


  36. YOUNG S
    Editorial Comment: Echocardiography-Should It Be Routine Before Elective TIPS?
    AJR Am J Roentgenol. 2022 Mar 2. doi: 10.2214/AJR.22.27580.
    PubMed    


  37. TANG A
    Editorial Comment: LI-RADS LR-2 and LR-3 Observations-Benign or Not Benign?
    AJR Am J Roentgenol. 2022;218:471.
    PubMed    


    February 2022
  38. ALI A, Sarwar A, Patwardhan VR, Fraiche AM, et al
    Echocardiographic and Other Preprocedural Predictors of Heart Failure After TIPS Placement in Patients With Cirrhosis: A Single-Center 15-Year Analysis.
    AJR Am J Roentgenol. 2022 Feb 16. doi: 10.2214/AJR.21.26947.
    PubMed     Abstract available


  39. LOY LM, Low HM, Choi JY, Rhee HJ, et al
    Variant Hepatocellular Carcinoma Subtypes According to the 2019 WHO Classification: An Imaging-Focused Review.
    AJR Am J Roentgenol. 2022 Feb 16. doi: 10.2214/AJR.21.26982.
    PubMed     Abstract available


  40. BAE JS, Lee DH, Lee SM, Suh KS, et al
    Performance of LI-RADS Version 2018 on CT for Determining Eligibility for Liver Transplantation According to Milan Criteria in Patients at High Risk for Hepatocellular Carcinoma.
    AJR Am J Roentgenol. 2022 Feb 9. doi: 10.2214/AJR.21.27186.
    PubMed     Abstract available


  41. YANG C, Chen Q, Zhou C, Liu J, et al
    FIPS Score for Prediction of Survival After TIPS Placement: External Validation and Comparison With Traditional Risk Scores in a Cohort of Chinese Patients With Cirrhosis.
    AJR Am J Roentgenol. 2022 Feb 9. doi: 10.2214/AJR.21.27301.
    PubMed     Abstract available


  42. MELLNICK VM
    Editorial Comment: Increased liver lesion visualization on CT without increased cost.
    AJR Am J Roentgenol. 2022 Feb 2. doi: 10.2214/AJR.22.27391.
    PubMed    


  43. GEE MS
    Editorial Comment: Novel Associations Between Quantitative MRI Metrics and Clinical Risk Scores in Young Patients With Autoimmune Liver Disease.
    AJR Am J Roentgenol. 2022 Feb 2. doi: 10.2214/AJR.22.27453.
    PubMed    


    January 2022
  44. MCCRARY J, Trout AT, Mahalingam N, Singh R, et al
    Associations Between Quantitative MRI Metrics and Clinical Risk Scores in Children and Young Adults With Autoimmune Liver Disease.
    AJR Am J Roentgenol. 2022 Jan 26. doi: 10.2214/AJR.21.27204.
    PubMed     Abstract available


  45. CHO KJ
    Editorial Comment: Bland Hepatic Artery Embolization (HAE) for Hepatic Malignancy-Can Bland HAE be Performed on an Outpatient Basis?
    AJR Am J Roentgenol. 2022 Jan 19. doi: 10.2214/AJR.22.27384.
    PubMed    


  46. BONGERS MN, Walter S, Fritz J, Bier G, et al
    Interindividual Comparison of Frequency-Selective Nonlinear Blending to Conventional CT for Detection of Focal Liver Lesions Using MRI as the Reference Standard.
    AJR Am J Roentgenol. 2022 Jan 12. doi: 10.2214/AJR.21.26922.
    PubMed     Abstract available


  47. RMILAH AA, Qrareya MN, Fleming C, Alkurashi AK, et al
    Association of Cirrhosis and Other Patient and Procedural Characteristics With Postembolization Syndrome after Bland Hepatic Artery Embolization for Hepatic Malignancy.
    AJR Am J Roentgenol. 2022 Jan 5. doi: 10.2214/AJR.21.26806.
    PubMed     Abstract available


  48. DILLMAN JR, Franck MD, Gandhi D, Pednekar AS, et al
    Agreement Between Automated and Clinically Reported Manual ROI-Based MR Elastography Liver Stiffness Measurements in Children and Young Adults.
    AJR Am J Roentgenol. 2022;218:163-164.
    PubMed     Abstract available


    December 2021
  49. XIAN MF, Huang Y, Xie WX, Pan KM, et al
    LR-M Observations on Contrast-Enhanced Ultrasound: Detection of Hepatocellular Carcinoma Using Additional Features in Comparison with Current LI-RADS Criteria.
    AJR Am J Roentgenol. 2021 Dec 15. doi: 10.2214/AJR.21.26837.
    PubMed     Abstract available


  50. LIU PS
    Editorial Comment: Is Quantitative CT Fat Fraction Ready For Prime Time?
    AJR Am J Roentgenol. 2021 Dec 15. doi: 10.2214/AJR.21.27184.
    PubMed    


  51. FETZER DT, Browning T, Xi Y, Yokoo T, et al
    Associations of Ultrasound LI-RADS Visualization Score With Examination-, Sonographer-, and Radiologist-Factors: Retrospective Assessment in Over 10,000 Examinations.
    AJR Am J Roentgenol. 2021 Dec 15. doi: 10.2214/AJR.21.26735.
    PubMed     Abstract available


  52. SCHIMA W
    Editorial Comment: Which MRI Contrast Agent for Hepatocellular Carcinoma Diagnosis in LI-RADS? The Fog is Lifting.
    AJR Am J Roentgenol. 2021 Dec 8. doi: 10.2214/AJR.21.27171.
    PubMed    


    November 2021
  53. GUO Z, Blake GM, Graffy PM, Sandfort V, et al
    Hepatic Steatosis: CT-based Prevalence in Adults in China and the United States and Associations with Age, Sex, and Body Mass Index.
    AJR Am J Roentgenol. 2021 Nov 24. doi: 10.2214/AJR.21.26728.
    PubMed     Abstract available


  54. RONG D, He B, Tang W, Xie S, et al
    Comparison of Gadobenate-Enhanced MRI and Gadoxetate-Enhanced MRI for Hepatocellular Carcinoma Detection Using LI-RADS Version 2018: A Prospective Intraindividual Randomized Study.
    AJR Am J Roentgenol. 2021 Nov 24. doi: 10.2214/AJR.21.26818.
    PubMed     Abstract available


    October 2021
  55. HAO F, Eghbalieh N, So A, Lee EW, et al
    Hepatic Plexus Nerve Block for Microwave Ablation of Hepatic Tumors.
    AJR Am J Roentgenol. 2021 Oct 27. doi: 10.2214/AJR.21.26779.
    PubMed     Abstract available


  56. STRUYCKEN L, Patel M, Kuo P, Hennemeyer C, et al
    Clinical and Dosimetric Implications of Calculating Lung Shunt Fraction for Hepatic Yttrium-90 Radioembolization Using SPECT/CT Versus Planar Scintigraphy.
    AJR Am J Roentgenol. 2021 Oct 27. doi: 10.2214/AJR.21.26663.
    PubMed     Abstract available


  57. CHERNYAK V
    Editorial Comment: Transitional or Hepatobiliary Phase Hypointensity Improves Sensitivity Without Loss of Specificity for Pathologically Viable HCC After Locoregional Treatment.
    AJR Am J Roentgenol. 2021 Oct 20. doi: 10.2214/AJR.21.26949.
    PubMed    


  58. CHERNYAK V, van der Pol CB, Vernuccio F, Yoshimitsu K, et al
    The Global Reading Room: Imaging Detection of Hepatocellular Carcinoma.
    AJR Am J Roentgenol. 2021 Oct 13. doi: 10.2214/AJR.21.26909.
    PubMed    


  59. RANATHUNGA D, Osman H, Islam N, McInnes MD, et al
    Progression Rates of LR-2 and LR-3 Observations on MRI to Higher LI-RADS Categories in Patients at High Risk for Hepatocellular Carcinoma: A Retrospective Study.
    AJR Am J Roentgenol. 2021 Oct 13. doi: 10.2214/AJR.21.26376.
    PubMed     Abstract available


  60. LIU J, Ma J, Yang C, Ye T, et al
    Reply to "Factors in Spleen Size After TIPS Placement".
    AJR Am J Roentgenol. 2021;217:1013.
    PubMed    


  61. GEMERY JM, Munger DP, Hoffer EK
    Factors in Spleen Size After TIPS Placement.
    AJR Am J Roentgenol. 2021;217:1013.
    PubMed    


  62. FERRAIOLI G
    Beyond the AJR: "Two-Dimensional Shear Wave Elastography Predicts Survival in Advanced Chronic Liver Disease".
    AJR Am J Roentgenol. 2021;217:1012.
    PubMed    


    September 2021
  63. DOHARE N, Madhusudhan KS, Malik R, Das P, et al
    Utility of Hepatic 2D Shear-Wave Elastography in Monitoring Response to Image-Guided Intervention in Children With Chronic Budd-Chiari Syndrome: A Prospective Study.
    AJR Am J Roentgenol. 2021 Sep 29. doi: 10.2214/AJR.21.26547.
    PubMed     Abstract available


  64. KIM YY, Kim MJ, Yoon JK, Shin J, et al
    Incorporation of Ancillary MRI Features into the LI-RADS Treatment Response Algorithm: Impact on Diagnostic Performance After Locoregional Treatment for Hepatocellular Carcinoma.
    AJR Am J Roentgenol. 2021 Sep 29. doi: 10.2214/AJR.21.26677.
    PubMed     Abstract available


  65. REIZINE E, Chalaye J, Mule S, Regnault H, et al
    Utility of Early Posttreatment PET/CT Evaluation Using FDG or (18)F-FCH to Predict Response to (90)Y Radioembolization in Patients With Hepatocellular Carcinoma.
    AJR Am J Roentgenol. 2021 Sep 8. doi: 10.2214/AJR.21.26485.
    PubMed     Abstract available


    August 2021
  66. SHARBIDRE KG
    Editorial Comment: Recurrence of Hepatocellular Carcinoma in Liver Transplants-Microvascular Invasion and Pathologic Staging of the Explant Liver.
    AJR Am J Roentgenol. 2021 Aug 18. doi: 10.2214/AJR.21.26681.
    PubMed    


  67. CUNHA GM, Hosseini M, Furlan A, Fowler K, et al
    Hepatocellular Carcinoma Staging: Differences Between Radiologic and Pathologic Systems and Relevance to Patient Selection and Outcomes in Liver Transplantation.
    AJR Am J Roentgenol. 2021 Aug 18. doi: 10.2214/AJR.21.26436.
    PubMed     Abstract available


    July 2021
  68. SEVCO TJ, Masch WR, Maturen KE, Mendiratta-Lala M, et al
    Ultrasound (US) LI-RADS: Outcomes of Category US-3 Observations.
    AJR Am J Roentgenol. 2021 Jul 14:1-7. doi: 10.2214/AJR.20.23447.
    PubMed     Abstract available


  69. PAUL RK, Vazirani R, McDermott JC, Kliewer MA, et al
    Identification of the Most Important Subset of Doppler, Laboratory, and Clinical Parameters for Serial TIPS Evaluation.
    AJR Am J Roentgenol. 2021;217:164-171.
    PubMed     Abstract available


    June 2021
  70. CHU HH, Kim JH, Shin YM, Won HJ, et al
    Percutaneous Radiofrequency Ablation for Recurrent Intrahepatic Cholangiocarcinoma After Curative Resection: Multivariable Analysis of Factors Predicting Survival Outcomes.
    AJR Am J Roentgenol. 2021 Jun 2:1-7. doi: 10.2214/AJR.20.23461.
    PubMed     Abstract available


  71. ARAKI T, Imaizumi A, Okada H, Sasaki Y, et al
    Anatomy of Left Inferior Phrenic Vein in Patients Without Portal Hypertension.
    AJR Am J Roentgenol. 2021 Jun 2:1-7. doi: 10.2214/AJR.20.23106.
    PubMed     Abstract available


    May 2021
  72. RIDDELL AM, Torkzad MR, Koh DM
    Reply to "Additional Considerations on Use of Abbreviated Liver MRI in Patients With Colorectal Liver Metastases".
    AJR Am J Roentgenol. 2021 May 19:W1-W2. doi: 10.2214/AJR.21.25747.
    PubMed    


  73. GRANATA V, Fusco R, Petrillo A
    Additional Considerations on Use of Abbreviated Liver MRI in Patients With Colorectal Liver Metastases.
    AJR Am J Roentgenol. 2021 May 19:W1. doi: 10.2214/AJR.21.25652.
    PubMed    


  74. MALONE CD
    Editorial Comment on "Ultrasound-Guided Portal Vein Access and Percutaneous Wire Placement in the Portal Vein Are Associated With Shorter Procedure Times and Lower Radiation Doses During TIPS Placement".
    AJR Am J Roentgenol. 2021;216:1299.
    PubMed    


    April 2021
  75. ROBBINS AJ, Ritter S, Markese M, Skube ME, et al
    Atypical Hepatic Steatosis Patterns on MRI After Total Pancreatectomy With Islet Autotransplant.
    AJR Am J Roentgenol. 2021 Apr 28:1-7. doi: 10.2214/AJR.20.23303.
    PubMed     Abstract available


  76. CHAVHAN GB, Yoo SJ, Lam CZ, Khanna G, et al
    Abdominal Imaging of Children and Young Adults With Fontan Circulation: Pathophysiology and Surveillance.
    AJR Am J Roentgenol. 2021 Apr 28:1-11. doi: 10.2214/AJR.20.23404.
    PubMed     Abstract available


  77. SQUIRES JH, McCarville MB
    Contrast-Enhanced Ultrasound in Children: Implementation and Key Diagnostic Applications.
    AJR Am J Roentgenol. 2021 Apr 28. doi: 10.2214/AJR.21.25713.
    PubMed     Abstract available


  78. KIM B, Won JH, Kim J, Kwon Y, et al
    Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma: Radiologic and Clinical Factors Predictive of Survival.
    AJR Am J Roentgenol. 2021 Apr 14:1-8. doi: 10.2214/AJR.20.23213.
    PubMed     Abstract available


  79. CHEN Y, Xia Y, Tolat PP, Long L, et al
    Comparison of Conventional Gadoxetate Disodium-Enhanced MRI Features and Radiomics Signatures With Machine Learning for Diagnosing Microvascular Invasion.
    AJR Am J Roentgenol. 2021 Apr 7:1-11. doi: 10.2214/AJR.20.23255.
    PubMed     Abstract available


  80. FERRAIOLI G, Barr RG
    Quantification of Liver Steatosis: Is CT Equivalent to PDFF?
    AJR Am J Roentgenol. 2021;216:W14.
    PubMed    


  81. CORNMAN-HOMONOFF J, Madoff DC
    Commentary on: "Rebleeding and Mortality Risk Are Increased by ACLF but Reduced by Pre-emptive TIPS".
    AJR Am J Roentgenol. 2021;216:878.
    PubMed    


    February 2021
  82. RIEDESEL EL
    Editorial Comment: Liver Fat Quantification by Ultrasound-Potential to Change Diagnosis and Management of Pediatric NAFLD.
    AJR Am J Roentgenol. 2021 Feb 10. doi: 10.2214/AJR.21.25594.
    PubMed    


  83. VAN DER POL CB, Dhindsa K, Shergill R, Zha N, et al
    MRI Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Impact of and Reduction in Ancillary Features.
    AJR Am J Roentgenol. 2021 Feb 3:1-8. doi: 10.2214/AJR.20.23031.
    PubMed     Abstract available


    September 2020
  84. BORHANI AA
    Editorial Comment on "Liver Steatosis Categorization on Contrast-Enhanced CT Using a Fully-Automated Deep Learning Volumetric Segmentation Tool: Evaluation in 1,204 Heathy Adults Using Unenhanced CT as Reference Standard".
    AJR Am J Roentgenol. 2020 Sep 30. doi: 10.2214/AJR.20.24764.
    PubMed    


  85. PICKHARDT PJ, Blake GM, Graffy PM, Sandfort V, et al
    Liver Steatosis Categorization on Contrast-Enhanced CT Using a Fully-Automated Deep Learning Volumetric Segmentation Tool: Evaluation in 1,204 Heathy Adults Using Unenhanced CT as Reference Standard.
    AJR Am J Roentgenol. 2020 Sep 16. doi: 10.2214/AJR.20.24415.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: